半胱氨酸蛋白酶抑制劑3(Cys-C)重組蛋白
Recombinant Cystatin C (Cys-C)
CST3; Cystatin 3; Gamma Trace; Post-Gamma-Globulin; Neuroendocrine Basic Polypeptide; Amyloid Angiopathy And Cerebral Hemorrhage
- 編號URPA896Hu01
 - 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
 - 來源原核表達
 - 宿主E.coli
 - 內毒素水平<1.0EU/µg(LAL法測定)
 - 亞細胞定位分泌
 - 預測分子量14.6kDa
 - 實際分子量15kDa(差異分析請參閱說明書)
 - 片段與標簽Ser27~Ala146 with N-terminal His Tag
 - 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
 - 性狀凍干粉
 - 純度> 80%
 - 等電點8.8
 - 
                    應用
                    Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載 英文說明書 中文說明書
 - 規(guī)格 10μg50μg 200μg 1mg 5mg
 - 價格 ¥ 492 ¥ 1230 ¥ 2460 ¥ 7380 ¥ 18450
 - 欲了解實際交易價格和更多情況,請與當?shù)亟?jīng)銷商聯(lián)系!
 
序列
                                
                            用法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質期內,在適當?shù)臈l件下存儲,損失率低于5%。
增值服務
相關產(chǎn)品
| 編號 | 適用物種:Homo sapiens (Human,人) | 應用(僅供研究使用,不用于臨床診斷!) | 
| URPA896Hu01 | 半胱氨酸蛋白酶抑制劑3(Cys-C)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| UAPA896Hu61 | 半胱氨酸蛋白酶抑制劑3(Cys-C)活性蛋白 | Cell?culture;?Activity?Assays. | 
| UEPA896Hu61 | 半胱氨酸蛋白酶抑制劑3(Cys-C)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| UPAA896Hu01 | 半胱氨酸蛋白酶抑制劑3(Cys-C)多克隆抗體 | WB; IHC; ICC/IF | 
| ULAA896Hu71 | 半胱氨酸蛋白酶抑制劑3(Cys-C)多克隆抗體(生物素標記) | WB; IHC; ICC. | 
| UMAA896Hu22 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體 | WB; IHC | 
| UMAA896Hu23 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體 | ICC/IF | 
| UMAA896Hu27 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體 | ICC/IF | 
| URAA896Hu21 | 半胱氨酸蛋白酶抑制劑3(Cys-C)重組抗體 | WB; IHC; ICC. | 
| URAA896Hu22 | 半胱氨酸蛋白酶抑制劑3(Cys-C)重組抗體 | WB; IHC; ICC. | 
| UMAA896Hu24 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體 | WB; IHC; ICC/IF | 
| UMAA896Hu25 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體 | WB | 
| UMAA896Hu26 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體 | WB | 
| UMAA896Hu21 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體 | WB; IHC; ICC/IF | 
| ULAA896Hu74 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體(生物素標記) | WB | 
| ULAA896Hu76 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體(生物素標記) | WB; IHC; ICC. | 
| UFAA896Hu54 | 抗半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體(別藻藍蛋白標記) | FCM | 
| USEA896Hu | 半胱氨酸蛋白酶抑制劑3(Cys-C)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| USCA896Hu | 半胱氨酸蛋白酶抑制劑3(Cys-C)檢測試劑盒(化學發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. | 
| ULMA896Hu | 半胱氨酸蛋白酶抑制劑3(Cys-C)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
| UPSA896Hu01 | 半胱氨酸蛋白酶抑制劑3(Cys-C)抗體對 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. | 
| UKSA896Hu01 | 半胱氨酸蛋白酶抑制劑3(Cys-C)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". | 
參考文獻
| 雜志 | 參考文獻 | 
| BioMed Research International | The Renal Effects of Vanadate Exposure: Potential Biomarkers and Oxidative Stress as a Mechanism of Functional Renal Disorders—Preliminary Studies [Hindawi: 740105] | 
| Critical Care | Endothelial dysfunction and renal fibrosis in endotoxemia-induced oliguric kidney injury: possible role of LPS-binding protein [Pubmed:25261195] | 
| РОЛЬ АПОПТОЗ ИНДУЦИРУЮЩЕГО ФАКТОРА И ОКИСЛИТЕЛЬНОГО СТРЕССА ПРИ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ [616-005.8] | |
| Journal of Agricultural and Food Chemistry | Protective Effects of DHA-PC against Vancomycin-Induced Nephrotoxicity through the Inhibition of Oxidative Stress and Apoptosis in BALB/c Mice [pubmed:29254330] | 
| THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE | Association of cathepsin B and cystatin C with an age-related pulmonary subclinical state in a healthy Chinese population [Pubmed: 32401159] | 
| RSC Adv | SERS based Y-shaped aptasensor for early diagnosis of acute kidney injury [Pubmed:35733690] | 
| Food Funct | A Compared Study of Gentle Ketogenic Diet Containing Medium-Chain Triglycerides or Long-Chain Triglycerides on Chronic Sleep Deprivation-Induced Cognitive?… [Pubmed:35141738] | 
    留言咨詢

                    
                    
                                    